tumor tissue array slides (Crown Bioscience)
90
Structured Review
Crown Bioscience
tumor tissue array slides
Tumor Tissue Array Slides, supplied by Crown Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tumor+tissue+array+slides/tumor+tissue+array+slides/pmc07774737-78-0-7
Average 90 stars, based on 1 article reviews
Tumor Tissue Array Slides, supplied by Crown Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tumor+tissue+array+slides/tumor+tissue+array+slides/pmc07774737-78-0-7
Average 90 stars, based on 1 article reviews
tumor tissue array slides - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer"
Article Title: An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer
Journal: Cancer Medicine
doi: 10.1002/cam4.3554
Figure Legend Snippet: Staining of non‐small cell lung cancer (NSCLC) cells and tissues by 16A (specific to GSTA neoantigen), SM3, and C595 (specific to PDTR neoantigen). (A) NSCLC cell lines were stained with 16A, SM3, and C595 antibodies. (B) Tissue array slides containing consecutive tissue sections from the same NSCLC patients were stained with 16A, SM3, and C595 antibodies.
Techniques Used: Staining
Figure Legend Snippet: Expression of the aberrantly glycosylated MUC1 peptide motif in lung and breast cancer tissues upon 16A antibody staining. (A) H‐score of the cancer tissue array stained with the 16A antibody. The intensity of IHC staining was scored at four levels: 0 (negative), 1 (weak staining), 2 (medium staining), and 3 (strong staining). The percentages of tumor cells at different intensity levels were evaluated. Total Score = (% at 0) ×0 + (% at 1) × 1 + (% at 2) ×2 + (% at 3) × 3. (B) 16A positivity in lung cancer, breast cancer, and triple‐negative breast cancer (TNBC) samples. (C, D, E, F) Representative photographs of MUC1 immunostaining in peritumoral (C), lung cancer (D), Non‐TNBC (E), and TNBC (F) tissue with the 16A antibody (original magnification ×200). Positivity was defined as ≥30% of tumor with staining ≥2+.
Techniques Used: Expressing, Staining, Immunohistochemistry, Immunostaining
Related Articles
Staining:Article Title: An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer Article Snippet: Expressing:Article Title: An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer Article Snippet: Immunohistochemistry:Article Title: An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer Article Snippet: Immunostaining:Article Title: An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer Article Snippet: |